Who should attend?

• CEOs & other senior executives from private & public biotech companies
• Senior representatives of leading Biotechnology Venture Capital funds
• Senior executives from top pharmaceutical and large biotech firms looking for partnering, acquisition and licensing opportunities
• Buy-Out and private equity professionals
• Specialised consultants & advisors
• Business & research institutes, universities
• Incubators, biotechnology parks, and media
• Leading biotech associations